T/FIF Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BulbaMan who wrote (503)	2/4/1999 7:38:00 PM
From: Mike McFarland	Read Replies (1) of 1073

I'd like to hear if anybody has an opinion on that Creative Biomolecules, which was listed in that article. I got an email from iionline today promoting it, normally I would not have even noticed it, but I recognized the name (from when Creative BioMolecules Licenses GDF-1 Neurotrophic Protein From Cambridge NeuroScience). The idea was cbmi may soon get approval... Developer: Creative BioMolecules Indication: bone graft substitute in non-union bone fractures Marketer(s): Styker Product: recombinant human osteogenic protein-1 in collagen matrix Current Status: PLA or NDA Filed Tradename: OP-1 --I freed up a little cash today to buy it, but then chickened out...well, actually I almost put in an order for another 5k of cnsi, but I stopped myself and might just sit on the cash for more than a day for a change, haha!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next